Showing results (771-780 of 2,556) with videos related to
Sort By:
Pageof 256
Therapeutics and Clinical Risk Management|February 17, 2022
Multivariable Analysis of Risk Factors Affecting Dislocation After Bipolar Hemiarthroplasty in Patients with Femoral Neck FractureYuhui Yang, Guangtao Fu, Qingtian Li, et al.Therapeutics and Clinical Risk Management|March 14, 2022
Effects of Combination Treatment in Hypertensive Patients with Depression: A Systematic Review and Meta-Analysis of 27 Randomized Controlled TrialsLin Wang, Qingqing Liu, Dongsheng Sun, et al.Therapeutics and Clinical Risk Management|March 14, 2022
Research Progress of Olfactory Nerve Regeneration Mechanism and Olfactory TrainingBian Hu, Jingyu Zhang, Mengdan Gong, et al.Therapeutics and Clinical Risk Management|March 25, 2022
Diagnosis and Management of Genetic Causes of Middle Aortic Syndrome in Children: A Comprehensive Literature ReviewCecilia Lazea, Camelia Al-Khzouz, Crina Sufana, et al.Therapeutics and Clinical Risk Management|April 7, 2022
The Role of D-Dimers in the Initial Evaluation of COVID-19Liliana Baroiu, Ana Cristina Lese, Ioana Anca Stefanopol, et al.Therapeutics and Clinical Risk Management|September 21, 2018
Th17/Treg homeostasis, but not Th1/Th2 homeostasis, is implicated in exacerbation of human bronchial asthmaXiao-Ling Zou, Zhuang-Gui Chen, Tian-Tuo Zhang, et al.Therapeutics and Clinical Risk Management|September 22, 2018
An unusual successful treatment with non-sulfonamides: primary cutaneous nocardiosis caused by Nocardia brasiliensisNian Chen, Qin Qin, Ke-Dai Sun, et al.Therapeutics and Clinical Risk Management|October 16, 2018
Effect of pharmaceutical care interventions on glycemic control in patients with diabetes: a systematic review and meta-analysisSohyun Jeong, Minhee Lee, Eunhee JiTherapeutics and Clinical Risk Management|March 3, 2022
Comparison of Outcome and Quality of Life Between Thulium Laser (VelaTM XL) Enucleation of Prostate and Bipolar Transurethral Enucleation of the Prostate (B-TUEP)Yu-Ting Chen, Chen-Pang Hou, Horng-Heng Juang, et al.Therapeutics and Clinical Risk Management|August 14, 2018
Angiotensin II: a new therapeutic option for vasodilatory shockRachel L Bussard, Laurence W BussePageof 256